Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Human Mutation|October 29, 2002
Five novel SLC7A7 variants and y+L gene-expression pattern in cultured lymphoblasts from Japanese patients with lysinuric protein intoleranceYutaka Shoji, Atsuko Noguchi, Yasuko Shoji, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 19, 2009
The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cellsKiyoshi Kikuchi, Ko-ichi Kawahara, Salunya Tancharoen, et al.
Microbiology Spectrum|December 1, 2021
Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging VariantsYoshitomo Morinaga, Hideki Tani, Yasushi Terasaki, et al.
Medical Hypotheses|August 24, 2010
Edaravone: a new therapeutic approach for the treatment of acute strokeKiyoshi Kikuchi, Ko-ichi Kawahara, Naohisa Miyagi, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Potential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarctionKiyoshi Kikuchi, Ko-Ichi Kawahara, Hisaaki Uchikado, et al.
Biochemical and Biophysical Research Communications|September 10, 2009
Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4Kiyoshi Kikuchi, Salunya Tancharoen, Fumiyo Matsuda, et al.
Biochemical and Biophysical Research Communications|April 22, 2009
Minocycline attenuates both OGD-induced HMGB1 release and HMGB1-induced cell death in ischemic neuronal injury in PC12 cellsKiyoshi Kikuchi, Ko-ichi Kawahara, Kamal Krishna Biswas, et al.
Experimental and Therapeutic Medicine|November 9, 2012
HMGB1: A new marker for estimation of the postmortem intervalKiyoshi Kikuchi, Ko-Ichi Kawahara, Kamal Krishna Biswas, et al.
Pageof 8